*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| N904 - Leukoplakia of vulva - as a primary diagnosis code | N904 - Leukoplakia of vulva - as a primary or secondary diagnosis code | |
|---|---|---|
| OUTCOMES | ||
| Avg. LOS | 4.48 | |
| Readmission Rate (%) | 16.16 | |
| Unplanned Readmission Rate (%) | NA | |
| Mortality Rate (%) | ||
| SNF Discharge Rate (%) | ||
| Home Discharge Rate (%) | ||
| PAYMENTS AND CHARGES | ||
| Total Medicare Payments | ||
| Payment Per Day | ||
| Payment Per Hospitalization | ||
| Total Medicare Charges | ||
| Avg. Charges | ||
| MARKET SIZING & INCIDENCE RATES | ||
| Total National Projected Hospitalizations - Annualized (Present on Admission - All) | ||
| Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - All) | ||
| Total National Projected Hospitalizations - Annualized (Present on Admission - Yes) | ||
| Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - Yes) | ||
| Total National Projected Hospitalizations - Annualized (Present on Admission - Not Y) | ||
| Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - Not Y) | ||
| Total Medicare Hospitalizations after Exclusion | ||
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 747: VAGINA, CERVIX AND VULVA PROCEDURES WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
|---|---|
| Total Hospitalizations at DRG | 5,216 |
| Total Hospitalizations with ICD N904 - Leukoplakia of vulva | 12 |
| DRG Share of Total Hospitalizations | 0.02 |
| % of Total ICD N904 - Leukoplakia of vulva in DRG | 48.0 |
| Avg LOS at DRG | 1.8 |
| Avg LOS with ICD N904 - Leukoplakia of vulva | 2.17 |
| Readmission Rate at DRG | 6.99 |
| Readmission Rate with ICD N904 - Leukoplakia of vulva | NA |
| Unplanned Readmission Rate at DRG | 4.34 |
| Unplanned Readmission Rate with ICD N904 - Leukoplakia of vulva | NA |
| Total Medicare payments at DRG | $29,263,906 |
| Total Medicare payments with ICD N904 - Leukoplakia of vulva | $55,017 |
| Total Medicare payment per Day at DRG | $3,119 |
| Total Medicare payment per Day with ICD N904 - Leukoplakia of vulva | $2,116 |
| Total Medicare payment per Hospitalization at DRG | $5,610 |
| Total Medicare payment per Hospitalization with ICD N904 - Leukoplakia of vulva | $4,585 |
| Total Medicare Charges at DRG | $184,533,401 |
| Total Medicare Charges with ICD N904 - Leukoplakia of vulva | $271,577 |
| Avg Charges at DRG | $35,378 |
| Avg Charges with ICD N904 - Leukoplakia of vulva | $22,631 |
| Mortality Rate at DRG | NA |
| Mortality Rate with ICD N904 - Leukoplakia of vulva | NA |
| SNF Discharge Rate at DRG | 4.47 |
| SNF Discharge Rate with ICD N904 - Leukoplakia of vulva | NA |
| Home Discharge Rate at DRG | 83.09 |
| Home Discharge Rate with ICD N904 - Leukoplakia of vulva | NA |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 747: VAGINA, CERVIX AND VULVA PROCEDURES WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 746: VAGINA, CERVIX AND VULVA PROCEDURES WITH COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 470: MAJOR JOINT REPLACEMENT OR REATTACHMENT OF LOWER EXTREMITY WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 743: UTERINE AND ADNEXA PROCEDURES FOR NON-MALIGNANCY WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 871: SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
|---|---|---|---|---|---|
| Total Hospitalizations at DRG | 5,216 | ||||
| Total Hospitalizations with ICD N904 - Leukoplakia of vulva | 117 | ||||
| DRG Share of Total Hospitalizations | 0.02 | ||||
| % of Total ICD N904 - Leukoplakia of vulva in DRG | 11.25 | ||||
| Avg LOS at DRG | 1.8 | ||||
| Avg LOS with ICD N904 - Leukoplakia of vulva | 1.89 | ||||
| Readmission Rate at DRG | 6.99 | ||||
| Readmission Rate with ICD N904 - Leukoplakia of vulva | 13.51 | ||||
| Unplanned Readmission Rate at DRG | 4.34 | ||||
| Unplanned Readmission Rate with ICD N904 - Leukoplakia of vulva | NA | ||||
| Total Medicare payments at DRG | $29,263,906 | ||||
| Total Medicare payments with ICD N904 - Leukoplakia of vulva | $671,117 | ||||
| Total Medicare payment per Day at DRG | $3,119 | ||||
| Total Medicare payment per Day with ICD N904 - Leukoplakia of vulva | $3,037 | ||||
| Total Medicare payment per Hospitalization at DRG | $5,610 | ||||
| Total Medicare payment per Hospitalization with ICD N904 - Leukoplakia of vulva | $5,736 | ||||
| Total Medicare Charges at DRG | $184,533,401 | ||||
| Total Medicare Charges with ICD N904 - Leukoplakia of vulva | $4,061,470 | ||||
| Avg Charges at DRG | $35,378 | ||||
| Avg Charges with ICD N904 - Leukoplakia of vulva | $34,713 | ||||
| Mortality Rate at DRG | NA | ||||
| Mortality Rate with ICD N904 - Leukoplakia of vulva | NA | ||||
| SNF Discharge Rate at DRG | 4.47 | ||||
| SNF Discharge Rate with ICD N904 - Leukoplakia of vulva | NA | ||||
| Home Discharge Rate at DRG | 83.09 | ||||
| Home Discharge Rate with ICD N904 - Leukoplakia of vulva | 72.65 |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 690: KIDNEY AND URINARY TRACT INFECTIONS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 872: SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 392: ESOPHAGITIS, GASTROENTERITIS AND MISCELLANEOUS DIGESTIVE DISORDERS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 734: PELVIC EVISCERATION, RADICAL HYSTERECTOMY AND RADICAL VULVECTOMY WITH COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 735: PELVIC EVISCERATION, RADICAL HYSTERECTOMY AND RADICAL VULVECTOMY WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
|---|---|---|---|---|---|
| Total Hospitalizations at DRG | 474,314 | ||||
| Total Hospitalizations with ICD N904 - Leukoplakia of vulva | 27 | ||||
| DRG Share of Total Hospitalizations | 1.44 | ||||
| % of Total ICD N904 - Leukoplakia of vulva in DRG | 2.6 | ||||
| Avg LOS at DRG | 3.53 | ||||
| Avg LOS with ICD N904 - Leukoplakia of vulva | 5.7 | ||||
| Readmission Rate at DRG | 18.03 | ||||
| Readmission Rate with ICD N904 - Leukoplakia of vulva | NA | ||||
| Unplanned Readmission Rate at DRG | 12.55 | ||||
| Unplanned Readmission Rate with ICD N904 - Leukoplakia of vulva | NA | ||||
| Total Medicare payments at DRG | $2,312,733,090 | ||||
| Total Medicare payments with ICD N904 - Leukoplakia of vulva | $135,460 | ||||
| Total Medicare payment per Day at DRG | $1,380 | ||||
| Total Medicare payment per Day with ICD N904 - Leukoplakia of vulva | $880 | ||||
| Total Medicare payment per Hospitalization at DRG | $4,876 | ||||
| Total Medicare payment per Hospitalization with ICD N904 - Leukoplakia of vulva | $5,017 | ||||
| Total Medicare Charges at DRG | $11,559,952,314 | ||||
| Total Medicare Charges with ICD N904 - Leukoplakia of vulva | $913,335 | ||||
| Avg Charges at DRG | $24,372 | ||||
| Avg Charges with ICD N904 - Leukoplakia of vulva | $33,827 | ||||
| Mortality Rate at DRG | 0.22 | ||||
| Mortality Rate with ICD N904 - Leukoplakia of vulva | NA | ||||
| SNF Discharge Rate at DRG | 25.96 | ||||
| SNF Discharge Rate with ICD N904 - Leukoplakia of vulva | NA | ||||
| Home Discharge Rate at DRG | 43.58 | ||||
| Home Discharge Rate with ICD N904 - Leukoplakia of vulva | 44.44 |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 603: CELLULITIS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 291: HEART FAILURE AND SHOCK WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 560: AFTERCARE, MUSCULOSKELETAL SYSTEM AND CONNECTIVE TISSUE WITH COMPLICATION OR COMORBIDITY (CC) | DRG 330: MAJOR SMALL AND LARGE BOWEL PROCEDURES WITH COMPLICATION OR COMORBIDITY (CC) | DRG 689: KIDNEY AND URINARY TRACT INFECTIONS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
|---|---|---|---|---|---|
| Total Hospitalizations at DRG | 364,421 | ||||
| Total Hospitalizations with ICD N904 - Leukoplakia of vulva | 14 | ||||
| DRG Share of Total Hospitalizations | 1.11 | ||||
| % of Total ICD N904 - Leukoplakia of vulva in DRG | 1.35 | ||||
| Avg LOS at DRG | 3.97 | ||||
| Avg LOS with ICD N904 - Leukoplakia of vulva | 4.21 | ||||
| Readmission Rate at DRG | 16.14 | ||||
| Readmission Rate with ICD N904 - Leukoplakia of vulva | NA | ||||
| Unplanned Readmission Rate at DRG | 10.98 | ||||
| Unplanned Readmission Rate with ICD N904 - Leukoplakia of vulva | NA | ||||
| Total Medicare payments at DRG | $1,924,528,848 | ||||
| Total Medicare payments with ICD N904 - Leukoplakia of vulva | $71,431 | ||||
| Total Medicare payment per Day at DRG | $1,332 | ||||
| Total Medicare payment per Day with ICD N904 - Leukoplakia of vulva | $1,211 | ||||
| Total Medicare payment per Hospitalization at DRG | $5,281 | ||||
| Total Medicare payment per Hospitalization with ICD N904 - Leukoplakia of vulva | $5,102 | ||||
| Total Medicare Charges at DRG | $8,912,106,420 | ||||
| Total Medicare Charges with ICD N904 - Leukoplakia of vulva | $265,228 | ||||
| Avg Charges at DRG | $24,456 | ||||
| Avg Charges with ICD N904 - Leukoplakia of vulva | $18,945 | ||||
| Mortality Rate at DRG | 0.09 | ||||
| Mortality Rate with ICD N904 - Leukoplakia of vulva | NA | ||||
| SNF Discharge Rate at DRG | 15.72 | ||||
| SNF Discharge Rate with ICD N904 - Leukoplakia of vulva | NA | ||||
| Home Discharge Rate at DRG | 53.33 | ||||
| Home Discharge Rate with ICD N904 - Leukoplakia of vulva | NA |
| Hospital Name | Address | City | State | Zip Code | Total Hospitalizations ( Oct 2015 to Sep 2018 ) |
|---|---|---|---|---|---|
| MAYO CLINIC HOSPITAL - SAINT MARYS CAMPUS | 1216 2ND ST SW | ROCHESTER | MN | 55902 | 31 |
| No | ICD Diagnosis Code | Description |
|---|---|---|
| 1 | I10 | Essential (primary) hypertension |